Serum Placental Growth Factor, Vascular Endothelial Growth Factor, Soluble Vascular Endothelial Growth Factor Receptor-1 and -2 Levels in Periodontal Disease, and Adverse Pregnancy Outcomes

Sert T., KIRZIOĞLU F. Y., FENTOĞLU Ö., Aylak F., Mungan T.

JOURNAL OF PERIODONTOLOGY, vol.82, no.12, pp.1735-1748, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 82 Issue: 12
  • Publication Date: 2011
  • Doi Number: 10.1902/jop.2011.100740
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1735-1748
  • Keywords: Cytokines, infant, low birth weight, periodontal diseases, preterm birth, vascular endothelial growth factors, TUMOR-NECROSIS-FACTOR, ALVEOLAR BONE LOSS, MATERNAL SERUM, PRETERM BIRTH, FACTOR-ALPHA, EXPRESSION, VEGF, PREECLAMPSIA, WOMEN, INTERLEUKIN-6
  • Süleyman Demirel University Affiliated: Yes


Background: The aim of this study is the evaluation of levels of serum interleukin (IL)-1 beta, IL-6, IL-10, tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor (VEGF), placental growth factor (PIGF), and soluble VEGF receptor (sVEGFR)-1 and -2 in the association between periodontal disease and adverse pregnancy outcomes.